• Prof. Avi Ben-Nun (1947-2019)

    “What furthered me most in life was that I dared to set high goals”, is what Prof. Ben-Nun used to say. He passed away on January 18, 2019, at the age of 72. He earned his master's degree in microbiology, cum laude, from Tel Aviv University in 1974 and his doctorate in immunology under the advice of Prof. Irun Cohen at the Weizmann Institute in 1981. A year later Avi moved to Boston for his postdoctoral studies at the Department of Genetics at Harvard Medical School. In 1984 he returned as a young scientist to the Department of Immunology at the Weizmann Institute. He was appointed Associate Professor in 1993 and received full professorship in 2007.

  • Prof. Michael Feldman (1926-2005)

    Professor Feldman graduated from the Hebrew University in Zoology and trained with noted embryologist and philosopher of science Conrad Hal Waddington at the Institute of Animal Genetics in Edinburgh. Michael joined the Weizmann Institute in 1955, was promoted to full professor in 1961, and at the same year founded the Department of Cell Biology, which he headed until his official retirement in 1990.

  • Prof. Ofer Lider (1955-2004)

    Ofer Lider began his PhD in 1983 in the Department of Immunology at the Weizmann Institute of Science, despite having recently been diagnosed with leukemia (CML). He completed his degree in the laboratory of Irun Cohen in 1987 and went on to a post-doctoral fellowship with Howard Weiner at the Harvard Medical School (1987-9). He returned to establish his own laboratory in the Department of Immunology, where he studied the regulation of the immune system and its interactions with the extra-cellular matrix (ECM). His unique research achievements earned him international acclaim and a professorship with tenure at the Weizmann Institute in 2001. Various treatments including two bone marrow transplantations failed to cure his leukemia, and Ofer Lider died in 2004 at the age of 49.

  • Prof. Israel Schechter (1935-2012)

    Israel Schechter first studied the active site of enzymes (proteases) discovering that their size is larger that expected, with important interactions in regions remote from the catalytic site allowing high binding energy of enzyme-inhibitor complexes. This led to rational design of inhibitors developed at 1990th into drugs against HIV (inhibitors of virus proteases) and revolutionized AIDs disease turning a lethal into a chronic disease. Other drugs were against hypertension, congestive heart failure, diabetes, cancer (methotrexate), bacteria (antibiotics), anti-viral (relenza) but also Viagra.

  • Prof. Nathan Trainin (1922-1999)

    Born in Argentina Nathan graduated Medical school of the University of Cordoba and made Aliya to Israel in 1949 with his wife Zila. They settled in Kibuz Maabarot where he served as a rural physician, riding on horse, visiting settlements of new immigrants. He then served in the IDF as a physician. After release from service in 1956, he joined the Department of Experimental Biology of the Weizmann Institute, headed by Prof. Isaac Berenblum.